We are live on ! Find out more
CBIO

Crescent Biopharma

58 hedge funds and large institutions have $82.9M invested in Crescent Biopharma in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

454% more call options, than puts

Call options by funds: $382K | Put options by funds: $69K

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

59% more capital invested

Capital invested by funds: $52.1M → $82.9M (+$30.8M)

18% more funds holding

Funds holding: 4958 (+9)

0.01% more ownership

Funds ownership: 0.54%0.55% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

Holders
58
Holders Change
+9
Holders Change %
+18.37%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
13
Reduced
13
Closed
6
Calls
$382K
Puts
$69K
Net Calls
+$313K
Net Calls Change
-$45K